UPDATE : Friday, June 14, 2019
상단여백
Il-yang to research Parkinson’s disease in Europe
Il-yang Pharmaceutical said Wednesday that it plans to start full-fledged c...
by Lee Han-soo  |  2019-03-28 16:28
라인
Allergan to resume marketing of macular edema treatment
Allergan Korea said Tuesday that it has started re-marketing Ozurdex (ingre...
by Lee Han-soo  |  2019-03-27 16:55
라인
JW Life Science wins nod for 3rd-generation nutrient infusion in Europe
JW Life Science said it has become Asia’s first pharmaceutical firm to sell...
by Jeong Sae-im  |  2019-03-27 16:16
라인
FDA OKs CrystalGenomics’ P1 trial for leukemia treatment
CrystalGenomics said Tuesday that Aptose Bioscience, its U.S. partner, has ...
by Lee Han-soo  |  2019-03-27 15:58
라인
‘Remimazolam has fewer side effects than propofol’
Hana Pharma said its new general anesthetic drug remimazolam demonstrated e...
by Jeong Sae-im  |  2019-03-27 15:05
라인
CJ Healthcare releases P3 trial results for gastroesophageal reflux treatment
CJ Healthcare said Tuesday that it has published a phase 3 clinical trial f...
by Lee Han-soo  |  2019-03-27 14:52
라인
AstraZeneca to launch Imfinzi in Korea next month
AstraZeneca said it would launch Imfinzi (ingredient: durvalumab), an immun...
by Lee Han-soo  |  2019-03-27 14:52
라인
Hanlim Pharm seeks to expand HL301’s indication for radiation pneumonitis
Hanlim Pharm said it would test HL301, a drug candidate for bronchitis, to ...
by Lee Hye-seon  |  2019-03-26 15:57
라인
Doctors outrageous over MSD Korea’s recordings of their talks
Korean doctors are enraged, criticizing MSD Korea’s alleged collection of f...
by Park Gi-taek  |  2019-03-25 16:05
라인
Daewoong releases P3 trial results for Nabota
Daewoong Pharmaceutical said Monday that it has published the U.S. phase 3 ...
by Lee Han-soo  |  2019-03-25 15:01
라인
Regulator OKs immunotherapies developed by multinational pharma companies
The Ministry of Food and Drug Safety (MFDS) approved Bavenico, a monoclonal...
by Lee Han-soo  |  2019-03-25 11:28
라인
Otsuka Korea CEO receives presidential citation
Otsuka Korea said Friday that Moon Sung-ho, the company’s CEO, received a p...
by Lee Han-soo  |  2019-03-22 16:52
라인
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials
Biogen announced on Thursday that it would discontinue the phase-3 trials o...
by Kim Yun-mi  |  2019-03-22 15:50
라인
Eubiologics gets nod to test botulinum toxin in phase-1 study
Eubiologics said it has begun developing a botulinum toxin product.The Mini...
by Lee Hye-seon  |  2019-03-22 15:28
라인
‘MSD Korea excessively monitors workers, collects client info without consent’
MSD Korea used to be called one of the best workplaces in the pharmaceutica...
by Jeong Sae-im  |  2019-03-22 13:49
라인
AbClon, C&R Research sign CRO contract
AbClon said Thursday that it has signed a contract research organization (C...
by Lee Han-soo  |  2019-03-21 17:17
라인
2 drugs for enlarged prostate not different in depression risk
Two classes of the drug for enlarged prostate -- 5-alpha reductase inhibito...
by Lee Hye-seon  |  2019-03-21 16:51
라인
SK Biopharmaceutical’s US partner gets FDA nod for sleepiness treatment
Jazz Pharmaceuticals, SK Biopharmaceutical’s U.S. partner, has received sal...
by Lee Han-soo  |  2019-03-21 15:26
라인
LG Chem licenses in PDC line’s anti-cancer vaccine
LG Chem said Thursday that it has signed a technology transfer agreement wi...
by Lee Han-soo  |  2019-03-21 11:17
라인
UK regulator OKs P1 trials of Shin Poong’s thrombotic disease treatment
Shin Poong Pharmaceutical said Tuesday that the U.K. Medicines and Healthca...
by Jeong Sae-im  |  2019-03-20 16:22
여백
여백
여백
Back to Top